Hepatitis C and drug user health: The latest international research and its implications for the frontlines

Updated October 25, 2019 with link to recording.

A new webinar from CATIE, in partnership with the International Network on Hepatitis in Substance Users (INHSU), is now available on demand.

Date Recorded: Monday October 21, 2019

Hepatitis C prevention, testing and treatment is a critical part of drug user health education and service delivery. Join us for a spotlight on key discussions and findings from the International Conference on Hepatitis Care in Substance Users (INHSU 2019).

This webinar highlighted important international issues and new research with a focus on hepatitis C in the context of drug user health. This webinar also discussed the relevance and implications of the international programming, policy and research for frontline practice in Canada.

Topics included:

  • Improving hepatitis C prevention, testing, treatment and care for people who use drugs
  • Programming approaches to hepatitis C and harm reduction service delivery that meet the needs of people who use drugs, including peer-based models and service delivery within the prison system
  • Decolonizing hepatitis C treatment and research: Indigenous-centred approaches
  • Re-thinking hepatitis C re-infection
  • Moving beyond hepatitis C to consider other health issues faced by people who use drugs

Moderator: Christopher Hoy, Knowledge Specialist, Hepatitis C Community Health Programming, CATIE

Speakers:

  • Rivka Kushner, Knowledge Specialist, Hepatitis C, CATIE
  • Carrielynn Lund, DRUM & SASH/CanHepC Coordinator, Canadian Aboriginal AIDS Network
  • Kellie Guarasci, Nurse Clinician, Cool Aid Community Health Centre
  • Alexe Morgan, Harm Reduction Project Coordinator, AIDS Committee of Newfoundland and Labrador

 

Watch now

Learn More

Learn about CATIE Programs and Resoources